Silencing a Tumorigenic Catalyst

  • Author: Melania Tesio
  • Published: 14 May 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Science/American Association for the Advancement of Science (AAAS)
thumbnail image: Silencing a Tumorigenic Catalyst

Isocitrate dehydrogenases (IDH) 1 and 2 are metabolic enzymes converting isocitrate to α-ketoglutarate. When mutated in their catalytic site, however, they reduce α-ketoglutarate to (R)-2-hydroxyglutarate, a tumorigenic metabolite. Consequently, mutant IDH1 promotes the growth of brain tumors (gliomas) and mutant IDH2 favors the development of blood cancers (acute myeloid leukemias).


Two American teams discovered novel small molecules that inhibit these mutant enzymes. Fang Wang, Agios Pharmaceuticals, Cambridge, MA, and colleagues developed AGI-6780, a heterocyclic urea sulfonamide that binds to mutant IDH2 in a unique allosteric site, thereby potently and selectively blocking its catalytic activity and the growth of leukemic cells. Similarly, Dan Rohle, Memorial Sloan-Kettering Cancer Center, New York, and co-workers identified AGI-5198, a compound which inhibits mutant IDH1 and suppresses gliomas growth without exerting toxic effects on healthy tissues.

The therapy of gliomas and acute myeloid leukemias might, therefore, benefit from the use of these new molecules.


Article Views: 2923

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH